Identifying deregulated TF/miRNA negative and double-negative feedback loops in prostate cancer

Ali Sobhi Afshar, Joseph Xu, John Goutsias

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Transcription factors (TFs) and MicroRNAs (miRNAs) are two important regulators of gene expression in cells. Although a wealth of information is available on how TFs bind their targets and carry out their regulatory roles, this is not true for miRNAs. Recent observations suggest a high level of coordination between transcriptional regulation by TFs and post-transcriptional regulation by miRNAs. Understanding TF/miRNA interactions and their roles in tumor initiation and progression is an important problem that may lead to systemic insights into the molecular biology of cancer and form a basis for the development of new diagnostic tools and therapeutic approaches. In this paper, we propose an integrated approach for identifying two types of TF/miRNA feedback loops deregulated in prostate cancer. Our approach can be used to assign context-dependent biological functions to TF/miRNA interactions and provide a better understanding of miRNA deregulation in cancer.

Original languageEnglish (US)
Title of host publication2013 IEEE Global Conference on Signal and Information Processing, GlobalSIP 2013 - Proceedings
Pages85-88
Number of pages4
DOIs
StatePublished - 2013
Event2013 1st IEEE Global Conference on Signal and Information Processing, GlobalSIP 2013 - Austin, TX, United States
Duration: Dec 3 2013Dec 5 2013

Publication series

Name2013 IEEE Global Conference on Signal and Information Processing, GlobalSIP 2013 - Proceedings

Other

Other2013 1st IEEE Global Conference on Signal and Information Processing, GlobalSIP 2013
Country/TerritoryUnited States
CityAustin, TX
Period12/3/1312/5/13

ASJC Scopus subject areas

  • Information Systems
  • Signal Processing

Fingerprint

Dive into the research topics of 'Identifying deregulated TF/miRNA negative and double-negative feedback loops in prostate cancer'. Together they form a unique fingerprint.

Cite this